These drugs could be as revolutionary as antibiotics...
| | | NanoViricides, Inc. (NYSE: NNVC)'s drug NV-387 could be a single way to treat all of the "tripledemic" viruses and more! The success of penicillin led to an explosion in the development of antibacterials. But what about fighting viruses? One NYSE-traded biotech company — NanoViricides, Inc. (NYSE: NNVC) — is on a solid footing to revolutionize the treatment of antiviral infections with game-changing antiviral nanomedicines. These drugs could be as revolutionary as antibiotics and do not rely on immune systems, making them great for seniors and children! The company's lead drug candidate, NV-387, is aimed at treating RSV, Covid-19, Long Covid, Influenza, Bird Flu H5N1, and other respiratory viral infections. NV-387 was substantially superior to the three approved drugs — namely Tamiflu®, Rapivab® , and Xofluza® against an Influenza H3N2 lethal lung viral infection study. NNVC believes that NV-387 is expected to possess strong antiviral activity against H5N1 "Bird Flu" as well, given that H5N1 viruses are known to bind to heparan sulfate proteoglycans, and based on the observed broad-spectrum activity of NV-387. NV-387 was also at least as good as TPOXX® in a model animal study for the development of Smallpox/Mpox drugs, in two different ways of acquiring infection. Also, it is said that NV-387 is capable of completely curing a lethal RSV lung virus infection in animals, leading to indefinite survival of the animals, as reported recently. There is no cure for RSV, and no approved drug for treatment of RSV infection other than the toxic last-resort drug ribavirin! NV-387 could be highly valuable for preparedness against novel viral epidemics and pandemics, all while building shareholder value for NanoViricides, Inc. (NYSE: NNVC)!
Regards, Interactive Offers, LLC | | | | | | This is a PAID ADVERTISEMENT provided to customers of Schaeffer's Investment Research. Although we have sent you this email, Schaeffer's does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above. To stop receiving these emails, unsubscribe.
Schaeffer's Investment Research
5151 Pfeiffer Road, Suite 450
Cincinnati, Ohio 45242
| | |
Post a Comment
Post a Comment